Feature Channels:

AIDS and HIV

Add to Favorites Subscribe Share
fbshare-AIDS and HIV

Showing results

12911300 of 1344
ahc-logo.gif

Article ID: 536321

Hospitalizations for Children with HIV Drop by Nearly Two Thirds

Agency for Healthcare Research and Quality (AHRQ)

The number of infants under age 2 with HIV who were hospitalized fell by 64 percent between 1998 and 2005. During the same period, hospitalizations for children and adolescents with HIV age 2 to 17 and for adults with HIV age 18 to 44 dropped by 41 percent and 31 percent, respectively.

Released:
17-Dec-2007 8:35 AM EST

Article ID: 535788

Creation of the Swiss Institute for Vaccine Research

Genevensis Healthcare Communications

Lausanne, Switzerland, 3 December 2007-- The Swiss Institute for Vaccine Research will be launched on December 5, 2007, in Lausanne, Switzerland. The new Institute will encompass the principal aspects of vaccine research to fight the three main infectious diseases : HIV/AIDS, tuberculosis and malaria. The Institute will also benefit from ongoing vaccine research in cancer and influenza.

Released:
3-Dec-2007 8:00 AM EST
Newswise: Are HIV Drugs Only Addressing Quantity versus Quality of Life Issues for Patients?

Article ID: 535698

Are HIV Drugs Only Addressing Quantity versus Quality of Life Issues for Patients?

Samaritan Pharmaceuticals

Expert Available for Interviews for World AIDS Day Coverage: On World AIDS Day, people all over the world join together to educate one another about the disease, remember those who lost their lives fighting the disease, raise funds, and take action to stop the spread of HIV. The theme for the 2007 World AIDS Day is "Stop AIDS: Keep the Promise- Leadership." The focus is on getting everyone, not just the government, to take initiative and provide leadership on fighting HIV/AIDS.

Released:
28-Nov-2007 8:55 AM EST
JHSPH-new-logo.jpg

Article ID: 535671

Studies Suggest HIV Subtype More Deadly Than Others

Johns Hopkins Bloomberg School of Public Health

Two studies found that people infected with HIV in Thailand die from the disease significantly sooner than those with HIV living in other parts of the world. The shorter survival time measured in the studies suggests that HIV subtype E, which is the most common HIV subtype in Thailand, may be more virulent than other subtypes of the virus.

Released:
27-Nov-2007 1:30 PM EST
Newswise: HIV and AIDS Research

Article ID: 535619

HIV and AIDS Research

Indiana University

This tip sheet discusses some of the AIDS- and HIV-related research conducted by Indiana University Bloomington sexual health experts, who discuss how the sexual behavior of young, rural singles is no less risky than their non-rural peers, bisexual men and AIDS/HIV prevention, and motivation for correct condom use. Dec. 1 is World AIDS Day.

Released:
26-Nov-2007 12:30 PM EST
iu_logo.gif

Article ID: 535516

USAID Grant Goes to Indiana and Moi Universities' Ampath Program to Combat AIDS in Kenya

Indiana University

AMPATH, a program that grew out of the partnership between Indiana University School of Medicine and the Moi (Kenya) University Teaching and Referral Hospital, has received a 5-year, $60-million grant to prevent and treat HIV/AIDS in Kenya. In addition, the IU School of Medicine will augment this with $6 million over the 5 years of the grant.

Released:
19-Nov-2007 4:35 PM EST
Wis_Square_logo_color.png
  • Embargo expired:
    15-Nov-2007 5:00 PM EST

Article ID: 535318

Virus Used to Create Experimental HIV Vaccines Directly Impairs the Immune Response

Wistar Institute

Leading efforts to create an HIV vaccine have hinged on the use of viruses as carriers for selected elements of the HIV virus. Recently, however, evidence has emerged that some of these so-called viral vector systems may undermine the immune system and should not be used for vaccine development. Now, a new study from scientists at The Wistar Institute provides strong support for the idea that some viral-vector vaccines may cause more harm than good.

Released:
12-Nov-2007 6:00 AM EST
  • Embargo expired:
    12-Nov-2007 8:00 PM EST

Article ID: 535257

New Study Looks At Long-Term Drug Costs For Treating AIDS In Brazil

Harvard T.H. Chan School of Public Health

AIDS continues to be a staggering global public health problem. However, little is known about the long-term costs associated with providing drugs to AIDS patients in developing countries. To study those long-term cost trends, researchers from the Harvard School of Public Health have performed the first detailed analysis of AIDS drug cost trends in Brazil.

Released:
8-Nov-2007 12:40 PM EST
uclahealthlogo.gif

Article ID: 535284

Study Finds Strong Demand for HIV Meds After High-Risk Sex

University of California, Los Angeles (UCLA), Health Sciences

People who do not have HIV but seek antiretroviral medications following high-risk sexual encounters are very likely to complete the full monthlong drug regimen. Moreover, there is a strong demand for publicly available post-exposure prophylaxis among high-risk populations in Los Angeles County.

Released:
9-Nov-2007 8:00 AM EST

Article ID: 534848

Scandal of Invisibility Plagues Countries with No Civil Registries

University of North Carolina at Chapel Hill

Most people in Africa and Asia are born and die without leaving a trace in any official records, giving policymakers and researchers little information on which to base public health decisions, a University of North Carolina at Chapel Hill researcher and colleagues say in a paper published today (Oct. 29, 2007) in the British medical journal The Lancet.

Released:
29-Oct-2007 3:40 PM EDT

Showing results

12911300 of 1344

Chat now!